Podcasts

Aripiprazole, brexpiprazole, and cariprazine

Publish date: April 2, 2018
By
Leslie Citrome, MD, MPH
Author and Disclosure Information

Leslie Citrome, MD, MPH, discusses the differences among 3 dopamine receptor partial agonists.

 

Recommended Reading

Decompensation in a 51-year-old woman with schizophrenia
MDedge Psychiatry
Strategies for managing medication-induced hyperprolactinemia
MDedge Psychiatry
Functional capacity, life skills critical for patients with schizophrenia
MDedge Psychiatry
Managing schizophrenia as a chronic disease linked to better outcomes
MDedge Psychiatry
Watch for QTc interval prolongation in patients taking antipsychotics
MDedge Psychiatry
Possible increased breast cancer risk found in women with schizophrenia
MDedge Psychiatry
Tardive dyskinesia is theme of awards competition for early career psychiatrists
MDedge Psychiatry
The crisis of poor physical health and early mortality of psychiatric patients
MDedge Psychiatry
A 10-year-old boy with ‘voices in my head’: Is it a psychotic disorder?
MDedge Psychiatry
Tardive dyskinesia: 5 Steps for prevention
MDedge Psychiatry